WallStreetZenWallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GILD past earnings growth

How has GILD's earnings growth performed historically?
Company
-26.21%
Industry
220.44%
Market
30.64%
GILD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
GILD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
GILD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

GILD past revenue growth

How has GILD's revenue growth performed historically?
Company
-0.09%
Industry
7.14%
Market
17.32%
GILD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GILD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
GILD's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

GILD earnings and revenue history

Current Revenue
$27.3B
Current Earnings
$4.6B
Current Profit Margin
16.8%
GILD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

GILD Return on Equity

Current Company
22.3%
Current Industry
46.8%
Current Market
186.2%
GILD's Return on Equity (22.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GILD announces earnings.

GILD Return on Assets

Current Company
7.3%
Current Industry
10.3%
GILD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GILD Return on Capital Employed

Current Company
13.05%
Current Industry
16.5%
GILD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GILD vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GILD$27.28B$8.88B$4.59B+0.88%+0.67%
AMGN$26.32B$12.17B$6.55B+2.87%+35.06%
GSK$35.33B$19.93B$18.02B-2.83%+53.18%
SNY$48.81B$15.31B$9.00B+2.12%-2.42%
BMY$46.16B$17.97B$6.33B+17.31%+37.24%
View Top General Drug Manufacturer Stocks

GILD earnings dates

Next earnings date
Apr 26, 2023

Gilead Sciences Earnings & Revenue FAQ

What were GILD's earnings last quarter?

On Invalid Date, Gilead Sciences (NASDAQ: GILD) reported Q4 2022 earnings per share (EPS) of $1.31, up 322.58% year over year. Total Gilead Sciences earnings for the quarter were $1.64 billion. In the same quarter last year, Gilead Sciences's earnings per share (EPS) was $0.31.

If you're new to stock investing, here's how to buy Gilead Sciences stock.

What was GILD's earnings growth in the past year?

As of Q1 2023, Gilead Sciences's earnings has grown -26.21% year over year. This is 246.65 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 220.44%. Gilead Sciences's earnings in the past year totalled $4.59 billion.

What is GILD's earnings date?

Gilead Sciences's earnings date is Invalid Date. Add GILD to your watchlist to be reminded of GILD's next earnings announcement.

What was GILD's revenue last quarter?

On Invalid Date, Gilead Sciences (NASDAQ: GILD) reported Q4 2022 revenue of $7.39 billion up 2% year over year. In the same quarter last year, Gilead Sciences's revenue was $7.24 billion.

What was GILD's revenue growth in the past year?

As of Q1 2023, Gilead Sciences's revenue has grown -0.09% year over year. This is 7.23 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 7.14%. Gilead Sciences's revenue in the past year totalled $27.28 billion.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.